<p>BEAS-2B cells were pre-treated and incubated for 1h with either PF956980 (○), PF1367550 (●), or dexamethasone (▲) followed by stimulation for 20h with IFNγ (10ng/ml) (panels a-c) or IFNγ + TNFα (10ng/ml) (panels d-f). Media was harvested and the concentrations of CXCL9 (panels a and d), CXCL10 (panels b and e) and CXCL11 (panels c and f) were measured by ELISA. Data are presented as mean±SEM, n = 7–8.</p
Background CD8+ T-cells are located in the small airways of COPD patients and may contribute to path...
The cell lines A) UM-SCC4 and B) UM-SCC47 were stimulated with 1μg/mL rituximab or 1μg/mL cetuximab ...
<p>Human primary airway epithelial cells were pre-treated for 1h in the presence of either PF956980 ...
<p>BEAS-2B cells were pre-treated with either PF956980 (checked bars), PF1367550 (hashed bars) or de...
<p>Human primary airway epithelial cells were pre-treated for 1h with either PF956980 (○), PF1367550...
<p>BEAS-2B cells were pre-treated for 1h in the presence of either PF956980 or PF1367550 prior to st...
<p>BEAS-2B cells were pre-treated for 1h with either PF956980 or PF1367550 followed by stimulation f...
<p>BEAS-2B cells were pre-treated with either PF956980 (PF956) or PF1367550 (PF136) for 1h followed ...
CD8+ T-cells are located in the small airways of COPD patients and may contribute to pathophysiology...
cells express the chemokine receptor, CXCR3 that binds CXCL9, CXCL10 and CXCL11, which are elevated...
<p>BEAS-2B cells, n = 11 (open bars, panels a, c and e) or human primary airway epithelial cells fro...
<p>BEAS-2B 2×GRE cells were pre-treated for 30 min with the indicated concentrations of A. the phosp...
<p>A, CXCL10 secretion, virtually absent in control, was significantly increased by 24γ (1000 U/ml) ...
<p>A, BXL-01-0029 (open triangles), elocalcitol (closed triangles), MTX (open squares), CsA (closed ...
<p>A. BEAS-2B cells stably transfected with a 2×glucocorticoid response element (GRE) luciferase rep...
Background CD8+ T-cells are located in the small airways of COPD patients and may contribute to path...
The cell lines A) UM-SCC4 and B) UM-SCC47 were stimulated with 1μg/mL rituximab or 1μg/mL cetuximab ...
<p>Human primary airway epithelial cells were pre-treated for 1h in the presence of either PF956980 ...
<p>BEAS-2B cells were pre-treated with either PF956980 (checked bars), PF1367550 (hashed bars) or de...
<p>Human primary airway epithelial cells were pre-treated for 1h with either PF956980 (○), PF1367550...
<p>BEAS-2B cells were pre-treated for 1h in the presence of either PF956980 or PF1367550 prior to st...
<p>BEAS-2B cells were pre-treated for 1h with either PF956980 or PF1367550 followed by stimulation f...
<p>BEAS-2B cells were pre-treated with either PF956980 (PF956) or PF1367550 (PF136) for 1h followed ...
CD8+ T-cells are located in the small airways of COPD patients and may contribute to pathophysiology...
cells express the chemokine receptor, CXCR3 that binds CXCL9, CXCL10 and CXCL11, which are elevated...
<p>BEAS-2B cells, n = 11 (open bars, panels a, c and e) or human primary airway epithelial cells fro...
<p>BEAS-2B 2×GRE cells were pre-treated for 30 min with the indicated concentrations of A. the phosp...
<p>A, CXCL10 secretion, virtually absent in control, was significantly increased by 24γ (1000 U/ml) ...
<p>A, BXL-01-0029 (open triangles), elocalcitol (closed triangles), MTX (open squares), CsA (closed ...
<p>A. BEAS-2B cells stably transfected with a 2×glucocorticoid response element (GRE) luciferase rep...
Background CD8+ T-cells are located in the small airways of COPD patients and may contribute to path...
The cell lines A) UM-SCC4 and B) UM-SCC47 were stimulated with 1μg/mL rituximab or 1μg/mL cetuximab ...
<p>Human primary airway epithelial cells were pre-treated for 1h in the presence of either PF956980 ...